TOI_OUT_1 [2025-03-24 13:42:39 -0400] 1923 Bytes | 515 tokens | Cum: 515 tkns (6.44% of 8k)
==========================================================================

We are in the 'Lightning Round' baby! It's 1:42:37 PM on Mon Mar 24, 2025 -0400, and I'm firing up the spotlight on The Oncology Institute (TOI), moving from 0.9962 to 1.21. Is this a can’t-miss rocket or a one-hit wonder? Let’s dissect the numbers!

Here's the first list of news for The Oncology Institute:

C1 - Today 09:05AM - Earnings To Watch: The Oncology Institute Inc (TOI) Reports Q4 2024 Result
C2 - 06:01AM - The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025
C3 - 06:00AM - The Oncology Institute Announces $16.5 million Private Placement
C4 - Mar-04-25 08:00AM - The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call
C5 - Feb-26-25 08:00AM - The Oncology Institute Announces Amendment to Facility Agreement and Debt Paydown
C6 - Dec-18-24 04:05PM - Florida Blue enhances cancer care for thousands of members
C7 - Nov-13-24 04:05PM - The Oncology Institute Reports Third Quarter 2024 Financial Results
C8 - Nov-11-24 08:00AM - The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on The Oncology Institute (TOI)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

TOI_OUT_3 [2025-03-24 13:42:43 -0400] 1048 Bytes | 302 tokens | Cum: 819 tkns (10.24% of 8k)
==========================================================================

Showing C2 (chunk 1 of 21): C2:
**The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025**
Date: 06:01AM
Source: (GlobeNewswire)
URL: https://www.globenewswire.com/news-release/2025/03/24/3047653/0/en/The-Oncology-Institute-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Guidance-for-2025.html

March 24, 2025 06:01 ET| Source:Toi Management, LLCToi Management, LLC

CERRITOS, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its fourth quarter and year ended December 31, 2024.

Daniel Virnich, CEO of TOI, commented, "I am very pleased with our performance in the fourth quarter of 2024. We were able to reduce our cash burn and generate positive cash flow from operations for a

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

TOI_OUT_5 [2025-03-24 13:42:49 -0400] 1039 Bytes | 212 tokens | Cum: 1033 tkns (12.91% of 8k)
==========================================================================

Showing C2 (chunk 2 of 21): second consecutive quarter, driven by disciplined working capital management. Additionally, both dispensary and value-based patient services are gaining widespread adoption in the marketplace, as we build around the chassis of our fee-for-service patient services business. As we enter 2025, we will continue to build on our momentum through strong operational management, increased efficiencies, and strategic market expansion."

TOI uses Adjusted EBITDA and Free Cash flow, each a non-GAAP metric, as an additional tool to assess its operational and financial performance. See "Financial Information: Non-GAAP Financial Measures" below. In reliance on the unreasonable efforts exception provided under Regulation S-K, TOI is not reasonably able to provide a quantitative reconciliation for forward-looking information of Adjusted EBITDA and Free Cash flow to net (loss) income and net cash provide

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

TOI_OUT_7 [2025-03-24 13:42:51 -0400] 939 Bytes | 271 tokens | Cum: 1423 tkns (17.79% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-24T17:06:05Z - 12 Health Care Stocks Moving In Monday's Intraday Session - Aditxt (NASDAQ:ADTX), Capstone Holding (...
A2 - 2025-03-24T10:48:52Z - Oncology Institute, Inc. Q4 Loss Drops...
A3 - 2025-03-24T10:43:04Z - The Oncology Institute (TOI) Announces $16.5M Private Placement...
A4 - 2025-03-24T10:39:04Z - The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for ...
A5 - 2025-03-24T10:03:07Z - The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance ......

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

TOI_OUT_9 [2025-03-24 13:42:52 -0400] 1038 Bytes | 318 tokens | Cum: 1743 tkns (21.79% of 8k)
==========================================================================

Showing A1 (chunk 1 of 3): A1:
**12 Health Care Stocks Moving In Monday's Intraday Session - Aditxt (NASDAQ:ADTX), Capstone Holding (NASDAQ:CAPS)**Date: 2025-03-24Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/movers/25/03/44461959/12-health-care-stocks-moving-in-mondays-intraday-sessionGainers Capstone Holding CAPS shares moved upwards by 75.6% to $3.02 during Monday's regular session. The market value of their outstanding shares is at $4.2 million. Kindly MD KDLY stock rose 57.28% to $2.38. The company's market cap stands at $14.1 million. Tonix Pharmaceuticals TNXP stock rose 26.24% to $29.07. The company's market cap stands at $187.0 million. As per the news, the Q4 earnings report came out 4 days ago. Lexeo Therapeutics LXEO shares moved upwards by 23.57% to $3.35. The company's market cap stands at $110.7 million. As per the news, the Q4 earning

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

TOI_OUT_11 [2025-03-24 13:42:54 -0400] 861 Bytes | 270 tokens | Cum: 2015 tkns (25.19% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2025-03-24T10:00:00Z - The Oncology Institute Announces $16.5 million Private Placement
B2 - 2024-11-21T12:00:00Z - Grapevine Saves The Oncology Institute Millions On Healthcare Supplies
B3 - 2024-11-05T00:09:00Z - The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call
B4 - 2024-09-30T12:00:00Z - The Oncology Institute of Hope & Innovation Launches Oregon Market
B5 - 2024-05-14T22:05:02Z - The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Lags Revenue Estimates
B6 - 2024-05-09T12:10:06Z - Viatris (VTRS) Q1 Earnings and Revenues Miss Estimates

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

TOI_OUT_13 [2025-03-24 13:42:58 -0400] 733 Bytes | 179 tokens | Cum: 2196 tkns (27.45% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**The Oncology Institute Announces $16.5 million Private Placement**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2025/03/24/3047652/0/en/The-Oncology-Institute-Announces-16-5-million-Private-Placement.htmlThe Oncology Institute, Inc. (TOI) announced a $16.5 million private placement with existing investors, management, and directors. The proceeds will be used for organic growth and working capital. The company also entered an exchange agreement with Deerfield Management Company to exchange convertible notes for preferred stock and warrants.

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

TOI_OUT_15 [2025-03-24 13:43:00 -0400] 1127 Bytes | 296 tokens | Cum: 2560 tkns (32.00% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-03-24 8-K Item7.01. Regulation FD Disclosure.

The Oncology Institute, Inc. (the Company) has prepared an investor presentation (the Investor Presentation) to use in meetings with investors. A copy of the Investor Presentation is furnished as Exhibit 99.1 to this Curr Report on Form 8-...

S2 - 2025-03-24 8-K Item 2.02. Results of Oper and Fin Cond

On March 24, 2025, The Oncology Institute, Inc. (the "Company") issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 31, 2024 and certain other financial informatio...

S6 - 2025-02-26 8-K Item 1.01. Entry into a Material Definitive Agrmt.

On February 26, 2025, The Oncology Institute, Inc. (the Company), the other loan parties party thereto, the lenders party thereto and Deerfield Partners, L.P. (the Agent), entered into that certain Limited Consent and Amend...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

TOI_OUT_17 [2025-03-24 13:43:06 -0400] 855 Bytes | 201 tokens | Cum: 2763 tkns (34.54% of 8k)
==========================================================================

Showing S1 (chunk 1 of 1): S1:
Item7.01. Regulation FD Disclosure.

The Oncology Institute, Inc. (the Company) has prepared an investor presentation (the Investor Presentation) to use in meetings with investors. A copy of the Investor Presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information contained in this Item 7.01, including Exhibit 99.1, is furnished and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, and such information shall not be deemed to be incorporated by reference into any of the Companys filings under the Securities Act or the Exchange Act....

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

TOI_OUT_19 [2025-03-24 13:43:19 -0400] 4939 Bytes | 1423 tokens | Cum: 4279 tkns (53.49% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+---------------------+-----------------------+----------------------+------------------------+-----------------------+----------------------+
| Volume: 1,084,494 | SMA50: 53.21% | Market Cap: 90.29M | Option/Short: No / Yes | Sales past 5Y: 15.26% | Sales Surprise: - |
+---------------------+-----------------------+----------------------+------------------------+-----------------------+----------------------+
| Avg Volume: 768.68K | SMA200: 161.81% | Shs Outstand: 75.56M | Short Float: 2.90% | Employees: 800 | EPS Surprise: - |
+---------------------+-----------------------+----------------------+------------------------+-----------------------+----------------------+
| Rel Volume: 2.26 | Perf Week: 70.47% | Shs Float: 36.80M | Short Ratio: 1.39 | Debt/Eq: 7.94 | P/E: - |
+---------------------+-----------------------+----------------------+------------------------+-----------------------+----------------------+
| RSI (14): 73.48 | Perf Month: 34.28% | Inst Own: 15.03% | Short Interest: 1.07M | Sales Y/Y TTM: 22.29% | Earnings: Mar 25 AMC |
+---------------------+-----------------------+----------------------+------------------------+-----------------------+----------------------+
| ATR (14): 0.13 | Perf Quarter: 541.78% | Insider Own: 51.29% | Beta: 0.34 | ROE: -131.66% | |
+---------------------+-----------------------+----------------------+------------------------+-----------------------+----------------------+
| SMA20: 52.06% | Index: - | Insider Trans: 0.78% | Sales Q/Q: 21.78% | ROI: -43.66% | |
+---------------------+-----------------------+----------------------+------------------------+-----------------------+----------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

Inside Trans: Oncology Institute, Inc. (TOI) by Carter Robert Ross (Chief Financial Officer) on 2025-03-19
- Class A Common Stock: 1150 shares at $0.889 (D)

Inside Trans: Oncology Institute, Inc. (TOI) by Podnos Yale (Chief Medical Officer) on 2025-03-19
- Common stock: 2975 shares at $0.889 (D)

Inside Trans: Oncology Institute, Inc. (TOI) by Virnich Daniel (Chief Executive Officer) on 2025-03-19
- Common stock: 10261 shares at $0.889 (D)

Inside Trans: Oncology Institute, Inc. (TOI) by Carter Robert Ross (Chief Financial Officer) on 2025-01-06
- Class A Common Stock: 258 shares at $0.335 (D)

[Company Financial Summary]
[Company Details]
Name: The Oncology Institute, Inc. Common Stock
Market Cap: 89605507.04249999
Shares Outstanding: 75559075
Sector: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 378933000.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -70235000.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 1.24
Average Volume: 598420.62
30-Day High: 1.24
30-Day Low: 0.6149

[Detailed Financials: Q3 2024]
- Total Assets: $179,183,000.0
- Total Liabilities: $163,701,000.0
- Total Equity: $15,482,000.0
- Current Assets: $116,425,000.0
- Current Liabilities: $46,757,000.0

[Income Statement: Q3 2024]
- Revenue: $99,901,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -0.18

[Cash Flow Statement: Q3 2024]
- Net Cash Flow: $10,978,000.0

[Detailed Financials: Q2 2024]
- Total Assets: $179,602,000.0
- Total Liabilities: $150,396,000.0
- Total Equity: $29,206,000.0
- Current Assets: $116,209,000.0
- Current Liabilities: $35,102,000.0

[Income Statement: Q2 2024]
- Revenue: $98,578,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -0.17

[Cash Flow Statement: Q2 2024]
- Net Cash Flow: $369,000
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

TOI_OUT_21 [2025-03-24 13:43:22 -0400] 676 Bytes | 167 tokens | Cum: 4692 tkns (58.65% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

TOI_IN_23 [2025-03-24 13:43:23 -0400] 126 Bytes | 29 tokens | Cum: 4748 tkns (59.35% of 8k)
==========================================================================

====================================
[2025-03-24 10:43:23] # Analysis Completed
Elapsed Time: 46.23 seconds